Furthermore, both the total gene mutation rate and single gene mutation rates (e.g., TP53, FOXA1, and ATM) were significantly higher in the high-risk group, consistent with reports that higher gene mutation rates are associated with more aggressive PCa, particularly in key cancer-associated genes38. This evidence concerns the gene FOXA1 and posterior cortical atrophy.